OX2 Therapeutics, Inc.
Biotechnology company · Minneapolis, Minnesota, United States
OX2 Therapeutics, Inc. is a biotechnology company headquartered in Minneapolis, Minnesota, United States. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $649,415 sold in a notice filed in 2020.
OX2 Therapeutics at a glance
What does OX2 Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $649,415 sold (2020).
Frequently asked questions about OX2 Therapeutics
Where is OX2 Therapeutics headquartered?
OX2 Therapeutics, Inc. is headquartered in Minneapolis, Minnesota, United States.
What does OX2 Therapeutics do?
OX2 Therapeutics, Inc. is a biotechnology company.
When was OX2 Therapeutics founded?
The earliest incorporation on record for OX2 Therapeutics, Inc. is in 2016, according to public company registers.
Similar companies
- Luminary Therapeutics, Inc.Minneapolis, Minnesota, United States
- Vergent Bioscience, Inc.Minneapolis, Minnesota, United States
- Objective Biotechnology, Inc.Minneapolis, Minnesota, United States
- Neurotype Inc.Minneapolis, Minnesota, United States
- BIO-TECHNE CorpMinneapolis, Minnesota, United States
- Photonic Pharma LLCMinneapolis, Minnesota, United States
- Metselex, IncorporatedMinneapolis, Minnesota, United States
- National Biomedical LLCMinneapolis, Minnesota, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences